Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats
Frontiers in Pharmacology · 19.07.2024 · 15
DOI: 10.3389/fphar.2024.1430599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.07.2024. Verfasst von Chao Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Hubei Provincial People’s Government.
Abstract (Originalsprache)
Sleep deprivation (SD) is commonplace in today’s fast-paced society. SD is a severe public health problem globally since it may cause cognitive decline and even neurodegenerative disorders like Alzheimer’s disease. Melatonin (MT) is a natural chemical secreted by the pineal gland with neuroprotective effects. The purpose of this study was to investigate the protective effect and mechanism of MT on chronic sleep deprivation-induced cognitive impairment. A 3-week modified multi-platform method was used to create the SD rat model. The Morris water maze test (MWM), Tissue staining (including Hematoxylin and Eosin (H & E) staining, Nissl staining, and immunofluorescence), Western blot, Enzyme-linked immunosorbent assay (ELISA), and Quantitative real-time polymerase chain reaction (qPCR) were used to investigate the protective effect and mechanism of MT in ameliorating cognitive impairment in SD rats. The results showed that MT (50 and 100 mg/kg) significantly improved cognitive function in rats, as evidenced by a shortening of escape latency and increased time of crossing the platform and time spent in the quadrant. Additionally, MT therapy alleviated hippocampus neurodegeneration and neuronal loss while lowering levels of pathogenic factors (LPS) and inflammatory indicators (IL-1β, IL-6, TNF-α, iNOS, and COX2). Furthermore, MT treatment reversed the high expression of Aβ42 and Iba1 as well as the low expression of ZO-1 and occludin, and inhibited the SD-induced TLR4/MyD88/NF-κB signaling pathway. In summary, MT ameliorated spatial recognition and learning memory dysfunction in SD rats by reducing neuroinflammation and increasing neuroprotection while inhibiting the TLR4/MyD88/NF-κB signaling pathway. Our study supports the use of MT as an alternate treatment for SD with cognitive impairment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
- Engineering Research Center of TCM Protection Technology and New Product Development for the Elderly Brain Health, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, China.
- Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, China.
Förderung
- Department of Science and Technology, Hubei Provincial People’s Government
Zitieren
APA
Yin, C., Zhang, M., Cheng, L., Ding, L., Lv, Q., Huang, Z., Zhou, J., Chen, J., Wang, P., Zhang, S., & You, Q. (2024). Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1430599
Vancouver
Yin C, Zhang M, Cheng L, Ding L, Lv Q, Huang Z, et al. Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1430599
BibTeX
@article{Yin2024,
author = {Yin, Chao and Zhang, Meiya and Cheng, Li and Ding, Li and Lv, Qing and Huang, Zixuan and Zhou, Jiaqi and Chen, Jianmei and Wang, Ping and Zhang, Shunbo and You, Qiuyun},
title = {Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1430599}
}
EUVIMED